{"id":45600,"date":"2026-01-22T10:00:56","date_gmt":"2026-01-22T10:00:56","guid":{"rendered":"https:\/\/ciaoup.it\/?p=45600"},"modified":"2026-01-22T10:00:56","modified_gmt":"2026-01-22T10:00:56","slug":"telangana-india-sets-global-ambition-with-next-gen-life-sciences-policy-2026-30","status":"publish","type":"post","link":"https:\/\/ciaoup.it\/?p=45600","title":{"rendered":"Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30"},"content":{"rendered":"

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE<\/p>\n

DAVOS, Switzerland, Jan. 22, 2026 \/PRNewswire\/ — The Government of Telangana, India today unveiled its\u00a0Next-Gen Life Sciences Policy 2026\u201330\u00a0at the World Economic Forum 2026 in Davos, signalling the State’s intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics, and sustainable bio-manufacturing.\u00a0<\/p>\n

The policy articulates a decisive shift from scale-driven manufacturing to\u00a0value-led, innovation-powered growth\u00a0and positions Telangana as a globally integrated life sciences hub across discovery, development, and deployment. With a clear ambition to rank among the\u00a0top five life sciences clusters worldwide by 2030, the policy targets\u00a0USD 25 billion in investments, creation of\u00a0500,000 high-quality jobs, and deeper integration into global life sciences value chains.\u00a0<\/p>\n

The manufacturing depth is increasingly complemented by\u00a0high-value R&D and innovation activity. Several global sciences organizations \u2014including Amgen, Sanofi, Bristol Myers Squibb, Lilly, among several others have established or expanded R&D, digital, and global capability centres in Hyderabad, reflecting confidence in the Telangana’s scientific talent and innovation-ready infrastructure.\u00a0<\/p>\n

The\u00a0Next-Gen Life Sciences Policy 2026\u201330 represents a deliberate scale-up, designed to accelerate Telangana’s transition from being indispensable to global supply chains to becoming a\u00a0global originator of advanced therapies and platforms. The policy was unveiled by the Chief Minister Mr. A. Revanth Reddy in the presence of Minister for IT & Industries, Mr. D. Sridhar Babu, Special Chief Secretary Mr. Sanjay Kumar IAS, and CEO, Telangana Lifesciences, Mr. Shakthi M. Nagappan. \u00a0\u00a0<\/p>\n

“We are building one of the world’s most trusted and transformational biosciences ecosystems\u2014driving global health impact from Telangana. The policy’s global unveiling at Davos reflects Telangana’s conviction that the next phase of growth in life sciences will be driven by\u00a0cross-border collaboration, global capital, and shared innovation agendas.” said Mr. A Revanth Reddy, Chief Minister of Telangana, India. \u00a0<\/p>\n

“The policy prioritizes\u00a0frontier science and advanced manufacturing platforms, including cell and gene therapies, peptides, precision fermentation, and other next-generation modalities. It strengthens the broader ecosystem across\u00a0clinical research, pharma services, diagnostics, medical electronics and digital health\u2014positioning Telangana as a preferred destination for global life sciences hubs”\u00a0 Mr. D. Sridhar Babu, Minister for IT, Electronics & Communications, and Industries, Government of Telangana\u00a0<\/p>\n

The policy implementation will be anchored by globally benchmarked infrastructure, including the Green Pharma City, ten Pharma Villages, expansion of Genome Valley, and further strengthening of the Medical Devices Park.\u00a0<\/p>\n

A dedicated\u00a0Life Sciences Innovation Fund, scalable up to\u00a0INR 1,000 crore (USD 100 million), will catalyze early- and growth-stage innovation, support deep-tech ventures, and crowd in private and institutional capital. This is supported by the establishment of the\u00a0Telangana School of Life Sciences, a university of global excellence focused on research, education, and future-ready talent development.\u00a0<\/p>\n

Telangana’s aspiration is anchored in a\u00a0mature, globally connected ecosystem that already operates at scale. Over the past two decades, the State has evolved from a manufacturing base into a full-spectrum life sciences hub spanning discovery research, clinical development, advanced manufacturing, and global operations.\u00a0<\/p>\n

Today, Telangana is home to\u00a0over 2,000 life sciences companies, hosts one of the world’s highest concentrations of\u00a0USFDA-approved pharmaceutical facilities, supplies\u00a0one-third of global vaccine demand, and serves as a trusted manufacturing and R&D partner to leading global life sciences companies. Companies in Hyderabad play a critical role in strengthening the resilience of global healthcare supply chains, particularly in vaccines, complex generics, biologics, and biosimilars.\u00a0<\/p>\n

Photo – https:\/\/mma.prnewswire.com\/media\/2866545\/Telengana.jpg
\n\u00a0<\/p>\n

\u00a0\u00a0<\/p>\n

View original content:https:\/\/www.prnewswire.co.uk\/news-releases\/telangana-india-sets-global-ambition-with-next-gen-life-sciences-policy-202630-302667067.html
\n\u00a0<\/p>\n

Copyright 2026 PR Newswire. All Rights Reserved.\u00a0<\/p>\n

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi<\/p>\n

—<\/p>\n

immediapress<\/p><\/p>\n

\n\t\t<\/a>\n\t\t<\/div>","protected":false},"excerpt":{"rendered":"

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE DAVOS, Switzerland, Jan. 22, 2026 \/PRNewswire\/ — The Government of…<\/p>\n","protected":false},"author":3,"featured_media":45601,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[23],"class_list":["post-45600","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-comunicati","tag-immediapress"],"_links":{"self":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts\/45600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45600"}],"version-history":[{"count":1,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts\/45600\/revisions"}],"predecessor-version":[{"id":45615,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts\/45600\/revisions\/45615"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/media\/45601"}],"wp:attachment":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}